Viewing Study NCT02565992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:42 PM
Ignite Modification Date: 2026-03-01 @ 1:26 PM
Study NCT ID: NCT02565992
Status: COMPLETED
Last Update Posted: 2023-01-17
First Post: 2015-09-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Intratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA)
Sponsor: Viralytics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pembrolizumab View
None Coxsackievirus A21 View
None melanoma View
None CAVATAK View
None CVA21 View
None checkpoint inhibitor View